NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

DEA issues letter to e-commerce companies over illegal pill-making machines

Published 02/26/2024, 06:42 PM
Updated 02/26/2024, 06:46 PM
© Reuters. Fentanyl pills found by officers from the Drug Enforcement Administration are seen in this handout picture, in New York, U.S., October 4, 2022. Drug Enforcement Administration/Handout via REUTERS/File Photo
EBAY
-

(Reuters) - The U.S. Drug Enforcement Administration issued a letter on Monday to e-commerce companies regarding the pill presses that are being used to make fentanyl pills.

The DEA has found pill presses, punches and other substances that can be used to make fake pills containing fentanyl are being offered for sale on various platforms.

In 2023, the DEA seized over 79 million fake pills containing fentanyl - a more than 33% increase from the year before.

The DEA's laboratory testing currently indicates that seven out of ten pills contain a potentially deadly dose of fentanyl.

"E-commerce platforms cannot turn a blind eye to the fentanyl crisis and to the sale of pill presses on their platforms. They must do their part to protect the public, and when they do not, DEA will hold them accountable," said DEA Administrator Anne Milgram.

Drug traffickers are using tableting and encapsulating machines - commonly referred to as pill presses - to press fentanyl into pills, and are imprinting marks and logos to make them look like legitimate prescription pills, the DEA said in the letter.

The pills contain fentanyl and other deadly drugs and are sold on social media, often to people who do not know that the pills are not real or that they contain deadly drugs, the federal agency said.

© Reuters. Fentanyl pills found by officers from the Drug Enforcement Administration are seen in this handout picture, in New York, U.S., October 4, 2022. Drug Enforcement Administration/Handout via REUTERS/File Photo

Last month, e-commerce platform eBay Inc (NASDAQ:EBAY) agreed to pay $59 million and to enhance its compliance program to resolve allegations that it violated the Controlled Substances Act (CSA) in connection with thousands of pill presses and encapsulating machines that were sold through its website.

As regulated entities under the CSA, e-commerce platforms are generally required to comply with recordkeeping, identification, and reporting requirements on the distribution, importation, and exportation of pill press machines.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.